News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Klobuchar Michael A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
4
| Klobuchar Michael A (EVP - Chief Strategy Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 885 shares
@ $118.22, valued at
$104.6k
Paid exercise price by delivering 436 shares
@ $118.22, valued at
$51.5k
Exercised 885 restricted stock units
@ $0 |
|
| 05/04/2023 |
4
| Klobuchar Michael A (EVP - Chief Strategy Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 20,747 options to buy
@ $117.89, valued at
$2.4M
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| Klobuchar Michael A (EVP - Chief Strategy Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 2,651 shares
@ $109.88, valued at
$291.3k
|
|
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Klobuchar Michael A (EVP - Chief Strategy Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 773 shares
@ $87.65, valued at
$67.8k
Paid exercise price by delivering 381 shares
@ $87.65, valued at
$33.4k
Exercised 773 restricted stock units
@ $0 |
|
| 05/03/2022 |
4
| Klobuchar Michael A (EVP - Chief Strategy Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 866 shares
@ $88.69, valued at
$76.8k
Paid exercise price by delivering 427 shares
@ $88.69, valued at
$37.9k
Exercised 866 restricted stock units
@ $0 |
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|